Alector, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Alector, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $48.00K, a 60.66% decline year-over-year.
- Alector, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $122.00K, a 81.06% decline year-over-year.
- Alector, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $644.00K, a 26.90% decline year-over-year.
- Alector, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $881.00K, a 1.73% increase year-over-year.
- Alector, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $217.00K, a 79.19% decline from fiscal 2024.
- Alector, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $1.04M, a 29.10% decline from fiscal 2023.
- Alector, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.47M, a 1.10% increase from fiscal 2022.
- Alector, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.46M, a 17.56% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $48.00K 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $217.00K 10-K · filed 2026-02-25 | |
| 2025-06-30 | $122.00K 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $1.04M 10-K · filed 2026-02-25 | |
| 2024-06-30 | $644.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $1.47M 10-K · filed 2025-02-26 | |
| 2023-06-30 | $881.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $1.46M 10-K · filed 2025-02-26 | |
| 2022-06-30 | $866.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $1.76M 10-K · filed 2024-02-27 | |
| 2021-06-30 | $969.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $1.18M 10-K · filed 2023-02-28 | |
| 2020-06-30 | $715.00K 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $798.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |